PAR 12.7% 31.0¢ paradigm biopharmaceuticals limited..

research reports and media, page-3417

 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.